Literature DB >> 16401746

Adult-onset nemaline myopathy and monoclonal gammopathy.

Christian E Keller1, Arthur P Hays, Lewis P Rowland, Behzad Moghadaszadeh, Alan H Beggs, Govind Bhagat.   

Abstract

A 45-year-old man with severe proximal muscle weakness had findings diagnostic of adult-onset nemaline myopathy. He also had a monoclonal gammopathy. This is the fifth report of adult-onset nemaline myopathy in a patient with monoclonal gammopathy, suggesting that the occurrence of these entities may be more than a chance association. Myocyte-bound immunoglobulin or light chains were not detected and immunotherapy was not effective in this patient. Other causes of adult-onset nemaline myopathy were ruled out, including the most common mutations of sarcomeric thin filament genes.

Entities:  

Mesh:

Year:  2006        PMID: 16401746     DOI: 10.1001/archneur.63.1.132

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  13 in total

1.  Progressive external ophthalmoplegia as initial manifestation of sporadic late-onset nemaline myopathy.

Authors:  Oliver Wengert; Andreas Meisel; Wolfram Kress; Gabriele Dekomien; Klemens Angstwurm; Frank L Heppner; Hans-Hilmar Goebel; Werner Stenzel
Journal:  J Neurol       Date:  2010-11-12       Impact factor: 4.849

Review 2.  [Treatability of sporadic late onset nemaline myopathy].

Authors:  F Hanisch; I Schneider; T Müller; B F Romeike; G Stoltenburg; H J Holzhausen; S Zierz
Journal:  Nervenarzt       Date:  2013-08       Impact factor: 1.214

3.  Sporadic late-onset nemaline myopathy in a patient with primary Sjögren's syndrome.

Authors:  Miki Suzuki; Yuko Shimizu; Megumi Takeuchi; Masaki Kobayashi; Makoto Iwata; Shinichiro Uchiyama
Journal:  J Neurol       Date:  2011-07-12       Impact factor: 4.849

4.  Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort.

Authors:  Mauro Monforte; Guido Primiano; Gabriella Silvestri; Massimiliano Mirabella; Marco Luigetti; Cristina Cuccagna; Enzo Ricci; Serenella Servidei; Giorgio Tasca
Journal:  J Neurol       Date:  2018-01-22       Impact factor: 4.849

5.  Clinical and pathological features of childhood-onset nemaline myopathy: a report of four cases.

Authors:  Chao Jiang; Jianping Wang; Haidong Lu
Journal:  Case Rep Med       Date:  2012-07-31

Review 6.  HIV-related neuromuscular diseases: nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia.

Authors:  L P Rowland
Journal:  Acta Myol       Date:  2011-06

7.  Nemaline myopathy and heart failure: role of ivabradine; a case report.

Authors:  Filippo M Sarullo; Giuseppe Vitale; Antonino Di Franco; Silvia Sarullo; Ylenia Salerno; Laura Vassallo; Emanuela Petrona Baviera; Stefania Marazia; Giorgio Mandalà; Gaetano A Lanza
Journal:  BMC Cardiovasc Disord       Date:  2015-01-19       Impact factor: 2.298

Review 8.  Sporadic late-onset nemaline myopathy: clinico-pathological characteristics and review of 76 cases.

Authors:  Lukas J Schnitzler; Tobias Schreckenbach; Aleksandra Nadaj-Pakleza; Werner Stenzel; Elisabeth J Rushing; Philip Van Damme; Andreas Ferbert; Susanne Petri; Christian Hartmann; Antje Bornemann; Andreas Meisel; Jens A Petersen; Thomas Tousseyn; Dietmar R Thal; Jens Reimann; Peter De Jonghe; Jean-Jacques Martin; Peter Y Van den Bergh; Jörg B Schulz; Joachim Weis; Kristl G Claeys
Journal:  Orphanet J Rare Dis       Date:  2017-05-11       Impact factor: 4.123

9.  Chemotherapy with stem cell transplantation is more effective than immunotherapy in sporadic late onset nemaline myopathy with monoclonal gammopathy.

Authors:  Rouslan Kotchetkov; Anna Dyszkiewicz-Korpanty; Vishal Kukreti
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

10.  Impact of hematologic complete response in the treatment of sporadic late-onset nemaline myopathy associated with monoclonal gammopathy.

Authors:  Tânia Maia; Rui Bergantim; Henrique Costa; Jorge Pinheiro; Fernanda Trigo
Journal:  Clin Case Rep       Date:  2021-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.